📣ICYMI📣 We shared some big news last week. That's right! Genezen can now support your project from the clinical to the commercial stage - no need for tech transfer. Contact Susan D'Costa, Megan Hardy, or Zuelay E. Rosario, PhD directly or reach out to us on our site: https://lnkd.in/ej5uSuAD #cdmo #viralvectors #pharma #biotech #precisionmedicine #finance #uniqure #csl #celltherapy #genetherapy #cellandgenetherapy #investment
Genezen
Biotechnology Research
Indianapolis, Indiana 4,418 followers
Accelerating the Pace of Cell Therapy CMC and Clinical Development
About us
Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide— making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. Genezen offers early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, building on the company's expansive knowledge and experience in the industry and working with the nation's leading institutions. For more information, or to learn more about services offered in Genezen's new cGMP facility, please visit our website: www.genezen.com
- Website
-
http://genezen.com
External link for Genezen
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Indianapolis, Indiana
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Retroviral vector, Lentiviral vector, Cell Banking, Process Development, Assay Development, Viral Vector Manufacturing, cGMP Manufacturing, and Viral Vector Testing
Locations
-
Primary
9900 Westpoint Dr
Indianapolis, Indiana 46256, US
Employees at Genezen
Updates
-
BIG NEWS! Genezen has signed an agreement to acquire uniQure’s commercial gene therapy manufacturing operations in Lexington, Massachusetts. This strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. Steve Favaloro, President and Chief Executive Officer of Genezen, commented, “...This acquisition significantly enhances Genezen’s scale and differentiated capabilities, directly aligned with our mission to advance cell and gene therapies by providing top-tier, science-driven development and manufacturing solutions. We are honored to deliver these services to our current customers and the patients they serve, and are well positioned to immediately extend our support to even more customers in Lexington.” #cdmo #viralvectors #cellandgenetherapy #celltherapy #genetherapy #precisionmedicine #mergersandacquisitions #investment #finance #pharma #biotech CSL Ampersand Capital Partners https://lnkd.in/eqDDc_cf
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA
prnewswire.com
-
😯 Whoops! Did you miss Susan D'Costa at BIO 2024? That's ok! Our team is ready to talk at your convenience. Contact Megan Hardy, Zuelay E. Rosario, PhD, Susan, or Pratima Cherukuri about your next project using viral vectors. Visit us to learn more: https://lnkd.in/etDM4Ek7. #cdmo #viralvectors #biotech #pharma #precisionmedicine #celltherapy #genetherapy #cellandgenetherapy
-
-
ICYMI: This Genezen and Univercells Technologies webinar explores revolutionary advancements in LVV production. https://lnkd.in/e4CH8PWa #cellandgenetherapy #genetherapy #celltherapy #biotech #pharma #viralvectors #precisionmedicine #cdmo #lentivirus
-
-
🌞 We had a wonderful week at BIO International. If you missed meeting with Susan D'Costa or Zuelay E. Rosario, PhD, don't worry! You can always request a conversation here: https://lnkd.in/ej5uSuAD. #cdmo #viralvectors #biotech #pharma #celltherapy #genetherapy #bio24 #cellandgenetherapy #precisionmedicine
-
-
The Genezen team recently packed 10,000 meals for Rise Against Hunger, a growing global movement to end hunger by empowering communities, nourishing lives, and responding to emergencies. #cdmo #viralvectors #biotech #pharma #precisionmedicine #celltherapy #genetherapy #cellandgenetherapy
-
-
ICYMI: Our VP of Quality and Regulatory Natasha Rivas recently had a featured article in Pharma's Almanac talking about the importance of regulatory in CDMO project partnerships. "To act as true partners for their clients, particularly younger biopharma companies new to the regulatory approval process, CDMOs that provide preclinical and clinical manufacturing services must be knowledgeable about regulatory expectations for the materials used in those studies." Read the article here: https://lnkd.in/evAGGMj3 #CGT #genetherapy #pharma #regulatory #cellandgenetherapy #celltherapy #biotech #viralvectors #precisionmedicine #cdmo
-
-
Book a meeting with Susan D'Costa at BIO 2024! You can message her directly or request time here: https://lnkd.in/eVrMQmeH. Better do it fast, she's pretty popular 😉 #cdmo #viralvectors #biotech #pharma #celltherapy #genetherapy #cellandgenetherapy #bio2024 #precisionmedicine
-
-
📣 Join our Chief Science Officer Pratima Cherukuri for a panel discussion on Friday evening during the ISCT, International Society for Cell & Gene Therapy meeting. Stop by booth 639 to talk with Pratima, Megan Hardy, and Zuelay E. Rosario, PhD about your cdmo viral vector needs. #cdmo #viralvectors #celltherapy #genetherapy #cellandgenetherapy #precisionmedicine #biotech #pharma #isct24
-
-
❗ Don't Miss Pratima Cherukuri's poster at ISCT, International Society for Cell & Gene Therapy! She will be available to answer questions at the poster session from 7-8:30pm and any time during the ISCT meeting at booth 639. #cdmo #viralvectors #celltherapy #genetherapy #cellandgenetherapy #precisionmedicine #biotech #pharma #isct24
-